JP2003513062A5 - - Google Patents

Download PDF

Info

Publication number
JP2003513062A5
JP2003513062A5 JP2001534755A JP2001534755A JP2003513062A5 JP 2003513062 A5 JP2003513062 A5 JP 2003513062A5 JP 2001534755 A JP2001534755 A JP 2001534755A JP 2001534755 A JP2001534755 A JP 2001534755A JP 2003513062 A5 JP2003513062 A5 JP 2003513062A5
Authority
JP
Japan
Prior art keywords
sertraline
solution
polymorph form
hydrogen chloride
seed crystal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2001534755A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003513062A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2000/010416 external-priority patent/WO2001032601A1/en
Publication of JP2003513062A publication Critical patent/JP2003513062A/ja
Publication of JP2003513062A5 publication Critical patent/JP2003513062A5/ja
Withdrawn legal-status Critical Current

Links

JP2001534755A 1999-10-29 2000-10-23 塩酸セルトラリンの多形形態 Withdrawn JP2003513062A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99810981.3 1999-10-29
EP99810981 1999-10-29
PCT/EP2000/010416 WO2001032601A1 (en) 1999-10-29 2000-10-23 Polymorphic forms of sertraline hydrochloride

Publications (2)

Publication Number Publication Date
JP2003513062A JP2003513062A (ja) 2003-04-08
JP2003513062A5 true JP2003513062A5 (cg-RX-API-DMAC7.html) 2007-12-06

Family

ID=8243113

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001534755A Withdrawn JP2003513062A (ja) 1999-10-29 2000-10-23 塩酸セルトラリンの多形形態

Country Status (17)

Country Link
US (2) US6872853B1 (cg-RX-API-DMAC7.html)
EP (1) EP1224160B1 (cg-RX-API-DMAC7.html)
JP (1) JP2003513062A (cg-RX-API-DMAC7.html)
CN (1) CN1384816A (cg-RX-API-DMAC7.html)
AR (1) AR026293A1 (cg-RX-API-DMAC7.html)
AT (1) ATE409684T1 (cg-RX-API-DMAC7.html)
AU (1) AU1386301A (cg-RX-API-DMAC7.html)
CA (1) CA2387135A1 (cg-RX-API-DMAC7.html)
DE (1) DE60040406D1 (cg-RX-API-DMAC7.html)
HU (1) HUP0203559A3 (cg-RX-API-DMAC7.html)
IL (2) IL149050A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA02004255A (cg-RX-API-DMAC7.html)
MY (1) MY141509A (cg-RX-API-DMAC7.html)
TR (1) TR200201146T2 (cg-RX-API-DMAC7.html)
TW (1) TWI260315B (cg-RX-API-DMAC7.html)
WO (1) WO2001032601A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200203254B (cg-RX-API-DMAC7.html)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1630156A1 (en) * 1998-11-27 2006-03-01 Teva Pharmaceutical Industries Ltd Sertraline hydrochloride polymorphs
IL143311A0 (en) * 1998-11-27 2002-04-21 Teva Pharma Sertraline hydrochloride polymorphs
US6500987B1 (en) * 1998-11-27 2002-12-31 Teva Pharmaceutical Industries Ltd. Sertraline hydrochloride polymorphs
US6495721B1 (en) 1999-08-09 2002-12-17 Teva Pharmaceutical Industries Ltd. Sertraline hydrochloride Form II and methods for the preparation thereof
US20050119351A1 (en) * 1999-10-29 2005-06-02 Van Der Schaaf Paul A. Polymorphic forms of sertraline hydrochloride
US7442838B2 (en) * 1999-10-29 2008-10-28 Ciba Specialty Chemicals Corp. Polymorphic forms of sertraline hydrochloride
EP1774965A3 (en) * 1999-12-21 2007-10-10 Teva Pharmaceutical Industries Ltd Novel sertraline hydrochloride polymorph, processes for preparing them, compositions containing them and methods of using them
YU47902A (sh) * 1999-12-21 2005-11-28 Teva Pharmaceutical Industries Ltd. Novi polimorfi sertralin hidrohlorida, postupci za njihovo dobijanje, preparati koji ih sadrže i postupci za njihovu upotrebu
IN192343B (cg-RX-API-DMAC7.html) * 2000-05-26 2004-04-10 Ranbaxy Lab Ltd
US7067700B2 (en) 2001-05-31 2006-06-27 Fermion Oy Process for preparing sertraline hydrochloride polymorphic form II
EP1499581A1 (en) 2002-04-29 2005-01-26 Teva Pharmaceutical Industries Ltd. Process for preparation of polymorphic form ii of sertraline hydrochloride, pharmaceutical formulations and methods of administration thereof
CN102215522A (zh) * 2002-06-27 2011-10-12 美商内数位科技公司 宽频码分多址第一无线网络控制器
JP2007502329A (ja) 2003-05-23 2007-02-08 トランスフォーム・ファーマシューティカルズ・インコーポレイテッド セルトラリン組成物
CA2544684A1 (en) 2003-11-04 2005-05-26 Cipla Limited Process for the preparation of polymorphs of selective serotonin reuptake inhibitor
EP1711493A2 (en) * 2004-02-06 2006-10-18 CIBA SPECIALTY CHEMICALS HOLDING INC. Patent Departement Crystalline forms of zolmitriptan
EP1893559A2 (en) * 2005-06-09 2008-03-05 Teva Pharmaceutical Industries Ltd Process for preparation of sertraline hydrochloride form i
US7518019B2 (en) 2006-06-01 2009-04-14 Hetero Drugs Limited Processes for preparing sertraline hydrochloride crystalline forms
CA2594198A1 (en) * 2007-07-20 2009-01-20 Apotex Pharmachem Inc. A novel process for the preparation of sertraline hydrochloride form ii
US9993793B2 (en) 2010-04-28 2018-06-12 The Procter & Gamble Company Delivery particles
US9186642B2 (en) 2010-04-28 2015-11-17 The Procter & Gamble Company Delivery particle
US8980292B2 (en) 2011-04-07 2015-03-17 The Procter & Gamble Company Conditioner compositions with increased deposition of polyacrylate microcapsules
WO2012138710A2 (en) 2011-04-07 2012-10-11 The Procter & Gamble Company Personal cleansing compositions with increased deposition of polyacrylate microcapsules
US8927026B2 (en) 2011-04-07 2015-01-06 The Procter & Gamble Company Shampoo compositions with increased deposition of polyacrylate microcapsules
CN105061217A (zh) * 2015-06-30 2015-11-18 徐静 枸橼酸舍曲林的2种晶型及其制备方法
EP4229164A1 (en) 2020-10-16 2023-08-23 The Procter & Gamble Company Consumer product compositions with at least two encapsulate populations
JP7719177B2 (ja) 2020-10-16 2025-08-05 ザ プロクター アンド ギャンブル カンパニー 封入体の集団を含む消費者製品組成物
US12486478B2 (en) 2020-10-16 2025-12-02 The Procter & Gamble Company Consumer products comprising delivery particles with high core:wall ratios
CN112552188B (zh) * 2020-12-17 2023-07-28 山西仟源医药集团股份有限公司 盐酸舍曲林晶型i的制备方法
CN113588626B (zh) * 2021-08-24 2024-05-24 上海师范大学 一种苯丙氨酸对映体的拉曼光谱检测方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4536518A (en) 1979-11-01 1985-08-20 Pfizer Inc. Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine
US5082970A (en) 1991-03-06 1992-01-21 Pfizer Inc. Process for recycling amine isomer
GB9114947D0 (en) 1991-07-11 1991-08-28 Pfizer Ltd Process for preparing sertraline
US5248699A (en) * 1992-08-13 1993-09-28 Pfizer Inc. Sertraline polymorph
US5734083A (en) * 1996-05-17 1998-03-31 Torcan Chemical Ltd. Sertraline polymorph
HU222341B1 (hu) 1996-12-18 2003-06-28 Richter Gedeon Vegyészeti Gyár Rt. Eljárás sertralin előállítására és az eljárásban alkalmazott intermedier
DE69713353D1 (de) * 1997-12-11 2002-07-18 Torcan Chemical Ltd Sertralin-Polymorph mit verbesserter Wasserlöslichkeit
CA2323629A1 (en) 1998-03-18 1999-09-23 Ciba Specialty Chemicals Holding Inc. Process for the cis-selective catalytic hydrogenation of cyclohexylidenamines
JP2000026378A (ja) 1998-07-03 2000-01-25 Sumika Fine Chemicals Co Ltd 塩酸セルトラリンの製法
US6500987B1 (en) 1998-11-27 2002-12-31 Teva Pharmaceutical Industries Ltd. Sertraline hydrochloride polymorphs
IL143311A0 (en) * 1998-11-27 2002-04-21 Teva Pharma Sertraline hydrochloride polymorphs
US6495721B1 (en) 1999-08-09 2002-12-17 Teva Pharmaceutical Industries Ltd. Sertraline hydrochloride Form II and methods for the preparation thereof
YU47902A (sh) 1999-12-21 2005-11-28 Teva Pharmaceutical Industries Ltd. Novi polimorfi sertralin hidrohlorida, postupci za njihovo dobijanje, preparati koji ih sadrže i postupci za njihovu upotrebu

Similar Documents

Publication Publication Date Title
CA2284750A1 (en) Steroid sulfamates, method for the production and use thereof
ZA200410000B (en) Method for producing C13-alcohol mixtures
CA2269053A1 (en) Crystals of benzimidazole derivatives and their production
RU2007113811A (ru) Способ получения оптически активных производных амина
AR030056A1 (es) Proceso para la preparacion de citalopram purificado
UA100367C2 (uk) Спосіб одержання мемантину і його гідрохлориду
MY141509A (en) Polymoprphic forms of sertraline hydrochloride
DE60135658D1 (de) In kaltem wasser lösliches -g(b)-glukanprodukt und verfahren zu dessen herstellung
JPS5967249A (ja) 塩化プロパルギルアンモニウムの製造方法
AR039857A1 (es) Preparaciones de una sulfinilacetamida
PE20040767A1 (es) Derivado hemisulfato de azido citosina cristalino anhidro
JP2002517370A5 (cg-RX-API-DMAC7.html)
JP2002538165A5 (cg-RX-API-DMAC7.html)
CO5720995A2 (es) Compuesto novedoso
CA2521877A1 (fr) Nouveau procede de synthese de l'acide (2s)-indoline-2-carboxylique, et application a la synthese du perindopril
CA2608919A1 (en) Novel organic compound and method for producing radioactive halogen-labeled organic compound using the same
BR0214742A (pt) Polimorfo cristalino de cloridrato de venlafaxina e métodos para sua preparação
JP2003012683A5 (cg-RX-API-DMAC7.html)
KR910000748A (ko) 결정성 세펨산 부가염 및 이의 제조 방법
Adkison et al. Semicarbazone-based inhibitors of cathepsin K, are they prodrugs for aldehyde inhibitors?
IT1318467B1 (it) Processo per la sintesi di cefoperazone sodico ad elevatacristallinita'.
JP2003515536A5 (cg-RX-API-DMAC7.html)
SE0201938D0 (sv) New process
UY26110A1 (es) Derivados de 2-alcoxi-ciclobuten-3,4-diona, su preparación y su aplicación en terapéutica
JP2005510559A5 (cg-RX-API-DMAC7.html)